In conclusion, our study is the first to demonstrate that NEK2 knockdown can deactivate the canonical Wnt/β-catenin signaling pathway in lung cancer cells, inhibites macrophage M2 polarization, angiogenesis, tumor growth, migration and metastasis. Here, NEK2 is linked to lung cancer.